activ
breath
control
abc
devic
employ
moder
deep
inspir
breath
hold
dibh
techniqu
order
spare
cardiac
structur
dose
left
breast
cancer
lbc
patient
commonli
practic
prone
posit
abc
also
help
reduc
dose
organ
risk
includ
lung
liver
howev
era
pandem
concern
regard
safeti
use
devic
risk
transmiss
amongst
multipl
patient
especi
sinc
viru
rel
high
transmiss
rate
increas
risk
fatal
elderli
patient
issu
particularli
poignant
cancer
patient
may
immunocompromis
increas
risk
invas
ventil
icu
admiss
death
vs
addit
altern
abc
prone
posit
may
provid
compar
benefit
abc
without
place
lbc
patient
situat
risk
direct
exposur
share
respiratori
devic
institut
util
activ
breath
elekta
stockholm
sweden
lbc
patient
previous
publish
result
prospect
trial
use
devic
demonstr
median
reduct
mean
heart
dose
mhd
gy
locoregion
relaps
rate
percent
addit
systemat
review
ten
studi
show
similar
result
dibh
includ
reduct
mhd
gy
translat
percent
decreas
risk
heart
diseas
includ
reduct
dose
left
anterior
descend
arteri
mean
dose
reduc
nearli
half
coronari
event
year
percent
percent
respiratori
droplet
one
main
method
transmit
viru
gener
cough
sneez
mouth
nose
breath
talk
size
number
droplet
vari
base
expiratori
activ
region
origin
respiratori
tract
type
pathogen
particl
report
diamet
rang
micron
viral
particl
aerosol
remain
viabl
hour
hour
plastic
stainless
steel
surfac
aerosol
model
healthi
human
measur
droplet
cough
small
micron
vast
major
percent
droplet
submicron
size
viral
aerosol
gener
influenza
tend
skew
toward
submicron
size
distribut
activ
breath
util
mouthpiec
filter
kit
design
singl
patient
use
viralbacteri
filter
construct
styreneacrylonitril
copolym
support
filter
media
construct
blend
modacryl
polypropylen
fiber
test
certifi
viral
bacteri
effici
fda
gmp
iso
fda
k
clearanc
filter
test
micron
size
particl
technic
provid
adequ
protect
transmiss
sinc
viru
may
small
micron
howev
elect
clinic
decid
whether
use
abc
casebycas
basi
due
concern
extra
precaut
time
pandem
provid
consid
altern
abc
patient
howev
includ
need
region
nodal
irradi
medial
later
lumpectomi
caviti
situat
anterior
displac
heart
toward
chest
wall
may
lead
effect
cardiac
spare
therefor
one
consid
simul
patient
prone
supin
posit
select
treatment
plan
suitabl
patient
field
imrt
summari
pandem
give
radiat
oncologist
opportun
evalu
standard
practic
creat
institut
guidelin
take
account
size
viru
type
devic
use
respiratori
gate
order
determin
riskbenefit
ratio
accept
patient
time
altern
abc
includ
voluntari
dibh
prone
posit
optim
treatment
plan
also
consid
mitig
risk
patient
heart
preserv
local
control
patient
left
breast
cancer
report
prospect
trial
